Kelly et al., 2015 [12] | Ann Surg | USA | 2003-2011 | R | 172 | 321 | 84 (49%) | 17 (53%) | 62 (26-92 | 57 (41-85) | 6 |
Lane et al., 2015 [13] | J Surg Onc | USA | - | R | 45 | 29 | 23 (51,1%) | 16 (55,2%) | 60 (52, 68) | 57 (51, 61) | 5 |
Nussbaum et al., 2016 [14] | Lancet Oncol | USA | 2003-2011 | R | 3322 | 563121962 | 1713 (51,5%) | 250 (44%)138 (52%) | 59,5 (± 14,5) | 59,2 (±13,8),59,5 (13,9) | 6 |
Pierie et al., 2006 [15] | EJSO | USA | 1973-1998 | P | 21 | 412 | N/A | N/A | N/A | N/A | 5 |
Smith et al., 2014 [16] | Radiother Oncol | Canada | 1996-2000 | R | 104 | 401 | 49 (47%) | 25 (62%) | N/A | N/A | 6 |
Stoeckle et al., 2001 [7] | Cancer | France | 1980-1994 | R | 55 | 892 | N/A | N/A | N/A | N/A | 5 |
Stucky et al., 2014 [17] | J Surg Onc | USA | 1996-2011 | R | 26 | 371 | 9 (35%) | 17 (46%) | 74 | 56 | 6 |
Toulmonde et al., 2014 [18] | Annals of Oncology | France | 1988-2008 | R | 262 | 127 | - | - | - | - | 5 |
Trovik et al., 2014 [19] | Acta Oncologica | Sweden | 1988-2009 | R | 55 | 42 | 22 (58,2%) | 15 (33%) | 63(15-83) | 61(35-82) | 6 |
Zhou et al., 2010 [20] | Arch Surg | USA | 1988-2005 | R | 1175 | 3722 | - | - | - | - | 5 |